StockData
ArriVent BioPharma, Inc. logo

ArriVent BioPharma, Inc. (AVBP) stock

AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$10.90+0.21 (+1.96%)

Close on Nov 18, 2026Market cap $537.45MP/E –Yield –

ArriVent BioPharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ArriVent BioPharma's market cap was $652.56M on Nov 11, 2026, against $937.15M a year earlier. Over the last 3 years it ranged from $45.36M to $1.57B, with a median of $795.82M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$652.56M-20.6%
2025Dec 31, 2025$821.95M-8.4%
2024Dec 31, 2024$897.62M–

More ArriVent BioPharma figures

See a number that looks wrong?